Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 1)
Dr. Katz

Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 1)

For over three decades, Dr. Ben Katz and his research team have been treating patients with chronic granulomatous disease (CGD) and working to build a better understanding of the disease…

Continue Reading Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 1)
Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 2)
Dr. Evan Dellon

Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 2)

Before you read on, make sure you've checked out Part 1 of our interview, where we discussed what eosinophilic esophagitis is, its symptoms and diagnostic criteria, and why Dr. Dellon chose to…

Continue Reading Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 2)
Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 1)
Dr. Evan Dellon

Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 1)

The U.S. Food and Drug Administration (FDA) approved Dupixent for the treatment of moderate-to-severe atopic dermatitis in patients aged 6 months+; the drug is also approved as add-on maintenance therapy…

Continue Reading Expanding Eosinophilic Esophagitis Research: An Interview with Dr. Evan Dellon (Pt. 1)
Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 3)
Photo courtesy of Anna Smith

Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 3)

Before you read, make sure you check out Parts 1 and 2 of our interview. In Part 1, we discussed what Wegener's granulomatosis (GPA) is, Anna's diagnostic journey, and her first episode of symptoms.…

Continue Reading Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 3)
Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 2)
Photo courtesy of Anna Smith

Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 2)

Before you read any further, make sure you've read Part 1 of our interview, where Anna and I discussed what Wegener's granulomatosis (GPA) is, her diagnostic journey, and how she managed her…

Continue Reading Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 2)
Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Granulomatosis (Pt. 1)
Photo courtesy of Anna Smith

Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Granulomatosis (Pt. 1)

When Anna tells me about her diagnosis of Wegener’s granulomatosis just about thirty years ago, she shares that she does all that she can to not allow it to encompass…

Continue Reading Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Granulomatosis (Pt. 1)

How Quris is Aiming to Address Fragile X (and Other Rare Diseases) through Bio-AI Drug Development (Pt. 2)

Before reading, don't forget to head to Part 1 to learn more about Quris' founder Isaac Bentwich, why Quris was developed, and how the company is using its innovative bio-AI drug development…

Continue Reading How Quris is Aiming to Address Fragile X (and Other Rare Diseases) through Bio-AI Drug Development (Pt. 2)

How Quris is Aiming to Address Fragile X (and Other Rare Diseases) through Bio-AI Drug Development (Pt. 1)

Many people laud the accomplishments of clinical trials – and for, in some cases, good reason. Clinical trials have been crucial in identifying and developing therapeutic options for patients to…

Continue Reading How Quris is Aiming to Address Fragile X (and Other Rare Diseases) through Bio-AI Drug Development (Pt. 1)
Pioneering RNA Therapeutics for Oncology: A Conversation with Geoff Nosrati of Nutcracker Therapeutics
Nutcracker Therapeutics micro logo

Pioneering RNA Therapeutics for Oncology: A Conversation with Geoff Nosrati of Nutcracker Therapeutics

Recent advances within the medical field have prompted the development of RNA therapeutics for many different applications. These therapeutics have the potential to greatly change the treatment landscape and create…

Continue Reading Pioneering RNA Therapeutics for Oncology: A Conversation with Geoff Nosrati of Nutcracker Therapeutics
Moonshots for Unicorns: The Quest to Cure PGAP3 – and Other Single-Gene Disorders (Pt. 1)
Photo courtesy of Zach and Geri Landman

Moonshots for Unicorns: The Quest to Cure PGAP3 – and Other Single-Gene Disorders (Pt. 1)

Zach and Geri Landman are devoted parents and physicians – a pain specialist and pediatrician, respectively – committed to making the world a better place for those around them. They…

Continue Reading Moonshots for Unicorns: The Quest to Cure PGAP3 – and Other Single-Gene Disorders (Pt. 1)

Getting On My Nerves 5K: How Jessica Dobbs Turned her Trigeminal Neuralgia Diagnosis Into Activism (Pt. 1)

When you think about a visit to the dentist, it may – at first – seem innocuous, something that you need to take care of for your health. But for…

Continue Reading Getting On My Nerves 5K: How Jessica Dobbs Turned her Trigeminal Neuralgia Diagnosis Into Activism (Pt. 1)
Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. 1)
Katheron Intson

Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. 1)

Katheron Intson is a passionate scientist; she likes understanding how and why things work the way that they do. So when Katheron’s friend reached out about a mysterious health problem,…

Continue Reading Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. 1)
Making a Difference: An Interview With Debra Miller on the Founding of CureDuchenne
source: pixabay.com

Making a Difference: An Interview With Debra Miller on the Founding of CureDuchenne

CureDuchenne is one of Patient Worthy's partner organizations. Patient Worthy partners with a variety of rare disease and patient-oriented non-profits in order to collaborate and help promote one another's activities.…

Continue Reading Making a Difference: An Interview With Debra Miller on the Founding of CureDuchenne

Chronic Illness, COVID-19, and Creative Writing: Discussing “Disposed: A Story of Chronic Illness During the COVID-19 Pandemic” with Dan Pezzetta (Pt. 2)

Make sure to check out Part 1 of our interview with Dan Pezzetta, an advocate for the rare disease and chronic illness communities. In Part 1, we dug into Dan's…

Continue Reading Chronic Illness, COVID-19, and Creative Writing: Discussing “Disposed: A Story of Chronic Illness During the COVID-19 Pandemic” with Dan Pezzetta (Pt. 2)